GBTC vs IBB
Grayscale Bitcoin Trust vs iShares Biotechnology ETF
GBTC$48.93
Grayscale Bitcoin Trust
Spot Bitcoin ETF from Grayscale.
Expense: 1.50%Yield: 0.00%
IBB$196.62
iShares Biotechnology ETF
NASDAQ biotech and pharmaceutical companies.
Expense: 0.44%Yield: 0.22%
Quick take
- • IBB has the lower expense ratio at 0.44% vs 1.50% for GBTC.
- • IBB pays a higher dividend yield (0.22%).
Side-by-side metrics
| Metric | GBTC | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 1.50% | 0.44% |
Dividend yield Trailing 12-month yield. | 0.00% | 0.22% |
AUM Assets under management — bigger funds are typically more liquid. | $8.13B | $9.09B |
YTD return | -29.43% | 16.44% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.00 | 0.69 |
P/E ratio | — | 24.79 |
Last price | $48.93 | $196.62 |
Inception | — | — |
Issuer | Grayscale | iShares |
GBTC top holdings
Holdings data unavailable for GBTC.
IBB top holdings
Top holdings · IBB
| VRTX | Vertex Pharmaceuticals Inc | 8.07% |
| AMGN | Amgen Inc | 7.82% |
| GILD | Gilead Sciences Inc | 6.83% |
| REGN | Regeneron Pharmaceuticals Inc | 4.90% |
| ARGX | argenx SE ADR | 3.75% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.12% |
| NTRA | Natera Inc | 2.89% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.78% |
| BIIB | Biogen Inc | 2.46% |
| ILMN | Illumina Inc | 2.07% |
Sector breakdown · IBB
Healthcare100.0%
About GBTC
GBTC (Grayscale Bitcoin Trust) is Spot Bitcoin ETF from Grayscale. Managed by Grayscale, the fund carries $8.1B in assets under management, an expense ratio of 1.50%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $9.1B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.22%. Its largest holding is Vertex Pharmaceuticals Inc (VRTX), which represents 8.1% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.